<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6977371/results/search/disease/results.xml">
  <result pre="10.4103/ijmr.IJMR_845_18 : Original Article Assessing the susceptibility of highly pathogenic" exact="avian influenza" post="H5N1 viruses to oseltamivir using embryonated chicken eggs TareDeeksha"/>
  <result pre="oseltamivir using embryonated chicken eggs TareDeeksha S.1KodeSadhana S.1HurtAeron C.3PawarShailesh D.2[1]," exact="Avian" post="Influenza Group, ICMR-National Institute of Virology-Microbial Containment Complex, Pune,"/>
  <result pre="Reference &amp;amp; Research on Influenza (VIDRL), Peter Doherty Institute for" exact="Infection" post="&amp;amp; Immunity, Melbourne VIC 3000, Australia For correspondence: Dr"/>
  <result pre="of embryonated chicken eggs for studying susceptibility of highly pathogenic" exact="avian influenza" post="(HPAI) H5N1 viruses to antiviral drugs. The aim of"/>
  <result pre="the allantoic cavity. In the eggs, 50 per cent egg" exact="infectious" post="dose (EID50) titres as well as mortality were quantitated."/>
  <result pre="after OC treatment was observed. Interpretation &amp;amp; conclusions: By measuring" exact="viral" post="titres, the egg model was suitable to study the"/>
  <result pre="viruses to OC. Antivirals embryonated chicken eggs H5N1 highly pathogenic" exact="avian influenza" post="oseltamivir The emergence of resistance among highly pathogenic avian"/>
  <result pre="avian influenza oseltamivir The emergence of resistance among highly pathogenic" exact="avian influenza" post="(HPAI) H5N1 viruses to oseltamivir has been an increasing"/>
  <result pre="to carry out regular antiviral surveillance of HPAI H5N1 viruses." exact="Advanced" post="molecular-based assays including Sanger sequencing, real-time reverse transcription polymerase"/>
  <result pre="vitro cell culture susceptibility studies have used Madin Darby Canine" exact="Kidney" post="cells, whereas in vivo studies include experiments in mice"/>
  <result pre="had a significant impact on reducing the severity of the" exact="disease" post="and survival8. Oseltamivir has also been known to prevent"/>
  <result pre="HPAI H5N1 virus9. For in vitro studies, a reduction in" exact="viral" post="haemagglutination (HA) titres was considered as a measure of"/>
  <result pre="the standard host system for the propagation and isolation of" exact="avian influenza" post="viruses11. Since the in ovo system (using embryonated chicken"/>
  <result pre="fluids of the eggs, were assessed as indicators of virus" exact="susceptibility to" post="the drug. The use of embryonated chicken eggs to"/>
  <result pre="to NAIs has been reported12. The susceptibility of low pathogenic" exact="avian influenza" post="viruses to oseltamivir carboxylate (OC), the active metabolite of"/>
  <result pre="strains provided by the International Society for Influenza and other" exact="Respiratory" post="Virus Diseases15 (ISIRV)-antiviral group namely, A/Mississippi/3/2001 (H1N1 wild type),"/>
  <result pre="used as controls. The experiments were carried out at the" exact="Avian" post="Influenza and High Containment Laboratory, ICMR-National Institute of Virology,"/>
  <result pre="were calculated using the curve-fitting software JASPR (v1.2, Centers for" exact="Disease" post="Control and Prevention, USA). Antiviral drug: For in ovo"/>
  <result pre="112 μg/ml doses were tested against 100 EID50 (50% egg" exact="infectious" post="dose) virus. OC concentrations of 14 μg/ml and above"/>
  <result pre="dose) virus. OC concentrations of 14 μg/ml and above showed" exact="complete" post="inhibition of the virus. Therefore, 14 μg/ml of OC"/>
  <result pre="the EID50 titres of 106.0 and 103.7, respectively, in the" exact="absence of" post="OC, as compared to the treated groups, which had"/>
  <result pre="OC, while the titres of 104.7 and 106.0 in the" exact="absence of" post="OC. Thus, there was no significant drop in EID50"/>
  <result pre="have been shown. Table Inhibitory concentration50 (IC50) values, 50% egg" exact="infectious" post="dose (EID50) and 50% egg lethal dose (ELD50) of"/>
  <result pre="(H1N1) Wild type 0.16 106.0* 0 No mortalityf A/Mississippi/3/2001 (H1N1)" exact="Variant" post="42.92 104.8 104.7 A/Perth/265/2009 (pH 1N1) Wild type 0.07"/>
  <result pre="(pH 1N1) Wild type 0.07 103.7* 0 A/Perth/265/2009 (pH 1N1)" exact="Variant" post="46.45 106.0 106.0 *P&amp;lt;0.05 compared to respective without drug"/>
  <result pre="out in three replicates each; eMean of EID50/ELD50 in the" exact="absence of" post="14 μg/ml oseltamivir carboxylate, carried out in three replicates"/>
  <result pre="of the virus in the brain9. HPAI H5N1 causes severe" exact="disease" post="in ferrets, and a significant reduction in morbidity and"/>
  <result pre="study, an influenza H3N2 virus was used to study the" exact="susceptibility to" post="NAIs12 wherein the survival rate of the embryos was"/>
  <result pre="assess the antiviral susceptibility. Therefore, it is important to standardize" exact="infectious" post="virus titres and select the virus dilutions accordingly in"/>
  <result pre="due to the observation that a significant reduction in the" exact="viral" post="HA titres was seen after treatment with OC for"/>
  <result pre="sampling. It has been observed that sometimes substitutions in the" exact="viral" post="NA protein do not necessarily lead to an apparent"/>
  <result pre="from poultry in Hong KongVirology1998252331429878612 3OIE update on highly pathogenic" exact="avian influenza" post="in animals (H5 and H7)accessed on November 13, 2018Available"/>
  <result pre="SwitzerlandWorld Health OrganizationAvailable from: http://wwwwhoint/csr/resources/publications/swineflu/h1n1_use_antivirals_20090820/en/ 5OIE update on highly pathogenic" exact="avian influenza" post="in animals (H5 and H7)accessed on November 13, 2018Available"/>
  <result pre="Res2018158143630125616 7OhDYHurtACA review of the antiviral susceptibility of human and" exact="avian influenza" post="viruses over the last decadeScientifica (Cairo)2014201443062924800107 8HurtACLowtherSMiddletonDBarrIGAssessing the development"/>
  <result pre="(H9N2) influenza virusesAntiviral Res2000481011511114412 10JacobASoodRChanuKhVBhatiaSKhandiaRPateriyaAKet al.Amantadine resistance among highly pathogenic" exact="avian influenza" post="viruses (H5N1) isolated from IndiaMicrob Pathog201691354026639679 11collab: World Health"/>
  <result pre="chicken egg as a model to study the susceptibility of" exact="avian influenza" post="H9N2 viruses to oseltamivir carboxylateJ Virol Methods2015224677226297959 14collab: World"/>
  <result pre="2018Available from: http://wwwwhoint/influenza/gisrs_laboratory/antiviral_susceptibility/nai_overview/en/ 15collab: International Society for Influenza and other" exact="Respiratory" post="Virus DiseasesAntiviral Working Group Panel Leaflet Panel of Influenza"/>
  <result pre="16PawarSDMurtadakVBKaleSDShindePVParkhiSSEvaluation of different inactivation methods for high and low pathogenic" exact="avian influenza" post="viruses in egg-fluids for antigen preparationJ Virol Methods2015222283325997377 17HurtACBarrIGHartelGHampsonAWSusceptibility"/>
 </snippets>
</snippetsTree>
